Sponsored by

NovoCure Trial

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 326 to 350 of about 5901

Previous 25

Website Changes

05/30/2023

GT Medical Technologies Marks a Clinical Milestone: 200th Patient Enrolled in the Multicenter Observational Registry of GammaTile® Therapy

05/30/2023

Racial and socioeconomic disparities in glioblastoma outcomes: A single-center, retrospective cohort study

05/22/2023

Updated NCCN Guidelines for Brain Tumors

05/22/2023

New legislation proposed to expedite FDA approval process for life-threatening disease treatments

05/20/2023

GT Medical Technologies Marks a Significant Milestone: The 1,000th Order for GammaTile® Therapy

05/20/2023

Congress should support a new strategy for approving lifesaving drugs

05/20/2023

Roon: The first patient and caregiver education GBM app

05/18/2023

Two Leading Nonprofits Join Forces to Fund Brain Tumor Research

05/18/2023

5K for brain tumor research (MN May 21, 2023)

05/11/2023

The Musella Foundation Celebrates 25 Years of Advancing Brain Tumor Research and Supporting Patients

05/10/2023

The Minnesota Brain Tumor 5K Announces 14th Annual Fun Walk/Run at Stillwater High School, May 21, 2023

05/08/2023

Join Us for Brain Tumor Awareness Month: Free Webinar Series on Innovative Treatments and Clinical Trials Tonight Monday May 8 at 7PM Eastern!

05/07/2023

Join Us for Brain Tumor Awareness Month: Free Webinar Series on Innovative Treatments and Clinical Trials, starts Tonight!

05/04/2023

Clinical trial has promising results to fight brain cancer

05/03/2023

Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines

05/02/2023

Join Us for Brain Tumor Awareness Month Webinar Series. Tonight`s topic is Pediatric Brain Tumors!

05/02/2023

Join Us for Brain Tumor Awareness Month: Free Webinar Series on Innovative Treatments and Clinical Trials

04/29/2023

Interstitial photodynamic therapy for newly diagnosed glioblastoma

04/26/2023

Seattle Children’s Launches Pioneering Immunotherapy Clinical Trial Targeting Four Antigens at the Same Time to Combat Pediatric Brain and Spinal Cord Tumors

04/24/2023

Gel has 100% success rate in stopping brain tumors in mice

04/24/2023

The Uncertainty of Clinical Trial Results

04/21/2023

Oblato Announces the First Enrollment in a Phase 1 Clinical Trial for an Oral Formulation of OKN-007 in Recurrent High-Grade Glioma Patients in the USA

04/21/2023

FDA About to Make Drug Approvals More Difficult

04/18/2023

UCLA BRAIN TUMOR CENTER TO HOST 23RD ANNUAL UCLA BRAIN TUMOR CONFERENCE

04/18/2023

Survey for Community Neuro-oncs!

Our privacy / cookie policy has changed.
Click HERE to read it!